VPN Plus+ ExclusiveFecal microbiota transplantation study results in fewer pooch paunchesOctober 20, 2022Now that the clinical phase of this trial is complete, the real work of data analysis begins. A first-of-its-kind multi-omics approach will evaluate the intestinal microbiota of participating dogs through DNA sequencing and measuring metabolites to assess functional changes in the gut. Winston notes even if FMT does not directly speed up weight loss, it could still have a powerful impact on health.
SPONSORED CONTENTHELP THEM FEEL COMFORTABLE IN THEIR OWN SKIN.Could the key to managing the constant itching and inflammation of canine atopic dermatitis be at the bottom of a bowl? + Learn More
Understanding nutrition in dogs with degenerative mitral valve diseaseJune 2, 2021A diagnosis of CHF in a dog requires commitment to a daily medication regimen and changes to the patient’s diet, which can be difficult to adjust to.
Studies supporting canine cancer prevention, treatment get fundingMay 10, 2021The AKC Canine Health Foundation has announced grants totaling more than $850,000 for 11 projects focused on canine oncology.
$108,000 donation supports canine health researchMarch 30, 2021The American Kennel Club (AKC) Canine Health Foundation (CHF) has received a donation totaling $108,872 from Purina.
Understanding nutrition in dogs with degenerative mitral valve diseaseJuly 6, 2020It is extremely helpful to introduce to clients the concepts of sodium restriction, adequate calorie and protein intake, and cardiac cachexia in the pre-CHF stage.
Understanding congestive heart failureFebruary 5, 2019Congestive heart failure (CHF) is described by medical professionals as more of a syndrome than a disease. Yet, when pet owners are often attuned to "disease," how can veterinarians best convey what CHF really is to their clients? "Congestive heart failure can result from a variety of different types of underlying heart disease," says Emily Karlin, DVM, Dipl. (cardiology), clinical instructor at Cummings School of Veterinary Medicine at Tufts University. "When we say CHF, we generally are referring to fluid buildup somewhere it should not be, as a result of heart dysfunction. We can see left-sided CHF (fluid buildup in the lungs—pulmonary edema), resulting in cough or trouble breathing, or right-sided CHF (fluid buildup in the abdomen or around the lungs—ascites or pleural effusion), resulting in abdominal distension or trouble breathing. Basically, CHF is a potential outcome of having heart disease." Recognizing signs and symptoms When it comes to differentiating CHF from heart disease, paying attention to clinical signs and symptoms is key. "Asymptomatic, or occult, heart disease is often detected based on physical exam abnormalities—such as a heart murmur, cardiac gallop, or arrhythmia—or sometimes by echocardiographic screening, but the animal is feeling well at home with no clinical …
AKC Canine Health Foundation funds clinical trial to study cannabidiol in treating drug-resistant epilepsy in dogsSeptember 14, 2017By Veterinary Practice News Editors The AKC Canine Health Foundation (CHF), which has funded more than $2 million for canine epilepsy research, launched an initiative in 2017 to further understand the most common neurological disorder that affects pure- and mixed-breed dogs. Improved treatments are urgently needed, especially for dogs with drug-resistant epilepsy or where side effects of currently available drugs are not tolerated, according to the organization. To that, the CHF has announced the beginning a major clinical trial to study the use of cannabidiol to treat drug resistant epilepsy in dogs. Stephanie McGrath, MS, DVM, DACVIM (Neurology), at Colorado State University's College of Veterinary Medicine and Biomedical Sciences, will lead "Efficacy of Cannabidiol (CBD) for the Treatment of Canine Epilepsy." According to Dr. McGrath, up to 30 percent of dogs receiving standard anti-epileptic therapy remain uncontrolled for their seizures, and the side effects of the antiepileptic drugs are often unacceptable. CBD, a nonpsychotropic component of the Cannabis sativa plant, has been shown to have anticonvulsant properties; this randomized, double-blinded, placebo-controlled, crossover clinical trial study will be utilized to prove its effectiveness, she stated. "The timeliness and importance of research into the role of cannabis in …
